摘要
Background: Traditional classification systems of metabolic-associated fatty liver disease (MAFLD) do not account for the high rate of extrahepatic complications. To create a new classification of MAFLD using metabolic pa-rameters to identify risks of complications more accurately.Methods: The retrospective study included MAFLD patients from the First Affiliated Hospital of Sun Yat-sen University for model development, and the model was validated respectively using Chinese cohort and UK Biobank database. Cluster analysis with k-means cluster was built using age, body mass index (BMI), glycosylated hemoglobin (HbA1c), total cholesterol/high density lipoprotein cholesterol (HDL-C) ratio, triglyceride, and li-poprotein(a) [Lp(a)] levels. Cox regression models were used to compare the risk of type 2 diabetes (T2DM), chronic heart disease (CHD), stroke and mortality between the clusters.Results: 1038 MAFLD patients from cross-sectional population were recruited for the model derivation, with 10,451 cases (33.4 % of MAFLD) from Chinese cohort and 304,141 cases (34.9 % of MAFLD, 1010 cases with magnetic resonance imaging proton density fat fraction measurement [MRI-PDFF]) from the international cohort validated. Five replicable clusters of MAFLD patients were identified: Cluster 1(mild obesity and dyslipidemia-related), Cluster 2 (age related), Cluster 3 (severe insulin resistance-related), Cluster 4[high Lp(a)-related], and Cluster 5 (severe mixed hyperlipidemia-related). Patients in different clusters exhibited differences in the development of T2DM, CHD, stroke and all-causes mortality. Patients in Cluster 3 had significantly worst survival outcomes and higher risks of T2DM and CVD than those in other clusters.Conclusion: The novel classification offers improved discrimination of new-onset MAFLD patients with different metabolic complications.
学科与关键词
- Discrepancies between Nonalcoholic and Metabolic- associated Fatty Liver Disease by Multiple Steatosis AssessmentShao, Congxiang; Ye, Junzhao; Li, Xin; Lin, Yansong; Feng, Shiting; Liao, Bing; Wang, Wei; Gong, Xiaorong*; Zhong, Bihui*Journal of Clinical and Translational Hepatology, 2022.被引 3
- Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver diseaseWang, Hongyan; Zhang, Yuxue; Liu, Yupeng; Li, Hui; Xu, Ruiling; Fu, Hongmei; Yan, Chaoqi*; Qu, Bo*Frontiers in Endocrinology, 2023, 14: 1163682.被引 2
- The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in ChinaYang, Rui-Xu; Zou, Zheng-Sheng; Zhong, Bi-Hui; Deng, Hong; He, Fang-Ping; Shi, Jun-Ping; Zhao, Cai-Yan; Mi, Yu-Qiang; Zhou, Yong-Jian; Di, Fu-Sheng; Zheng, Rui-Dan; Du, Qin; Shang, Jia; Popovic, Branko; Chen, JinJun*; Fan, Jian-Gao*Hepatobiliary & Pancreatic Diseases International, 2021, 20(5): 426-432.被引 9
